yes indeed. I mean let’s not be ageist. Also if you are not...

yes indeed. I mean let’s not be ageist. Also if you are not young / but not quite v old and have already seen 100’s of crappy ASX micro stocks come and hopefully seen what is shit and what is not it’s a decent place to park a medium amount of your risk aware funds:

- global eyesight pandemic driven by covid screentime
- unique myopia lense and IP
- not far off trading at cash backing
- Menicon launching white labelled day time disposables in Germany and UK next couple of months ($700 m revenue company)
- multiple myopia tie ups happening this year including johnson and Johnson white labelling Menicons nighttime lense.
- new product distribution agreements through existing US sales base

This is a slow burn but I am a very happy holder and completely ignore the short term SP now they have so many funds in the bank CR risk is removed.

the risks are there and known but It’s very very simple proposition:

1) If they become a small part of global myopia trend and get any decent sales from Menicon or new global partner tie ups will multibag from here

2) if they don’t, they won’t

too me based on all the evidence pointing to (1) being the outcome this is an absolute no brainer risk/reward and I am overweight accordingly

I suspect the answer will be very obvious in 1-2 years time